Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ATORVASTATIN Cause Blood cholesterol increased? 769 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 769 reports of Blood cholesterol increased have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 1.0% of all adverse event reports for ATORVASTATIN.

769
Reports of Blood cholesterol increased with ATORVASTATIN
1.0%
of all ATORVASTATIN reports
5
Deaths
155
Hospitalizations

How Dangerous Is Blood cholesterol increased From ATORVASTATIN?

Of the 769 reports, 5 (0.7%) resulted in death, 155 (20.2%) required hospitalization, and 26 (3.4%) were considered life-threatening.

Is Blood cholesterol increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 769 reports have been filed with the FAERS database.

What Other Side Effects Does ATORVASTATIN Cause?

Type 2 diabetes mellitus (7,556) Myalgia (7,155) Drug hypersensitivity (3,929) Drug ineffective (3,865) Fatigue (3,439) Arthralgia (3,338) Rhabdomyolysis (3,286) Dyspnoea (3,137) Nausea (2,888) Asthenia (2,791)

What Other Drugs Cause Blood cholesterol increased?

TOFACITINIB (5,062) ADALIMUMAB (4,264) TOCILIZUMAB (3,698) METHOTREXATE (3,567) RITUXIMAB (3,447) ABATACEPT (3,269) LEFLUNOMIDE (3,263) ALENDRONATE (3,114) ETANERCEPT (3,073) INFLIXIMAB (3,063)

Which ATORVASTATIN Alternatives Have Lower Blood cholesterol increased Risk?

ATORVASTATIN vs ATORVASTATIN\EZETIMIBE ATORVASTATIN vs ATOSIBAN ATORVASTATIN vs ATOVAQUONE ATORVASTATIN vs ATOVAQUONE\PROGUANIL ATORVASTATIN vs ATRACURIUM

Related Pages

ATORVASTATIN Full Profile All Blood cholesterol increased Reports All Drugs Causing Blood cholesterol increased ATORVASTATIN Demographics